glp-1 for alzheimer's Could diabetes and weight loss drugs treat disease? dpp 4 inhibitor and glp

PMID: 1700785

However, we must interpret these findings with caution, explicitly acknowledging the significant heterogeneity in study design, patient cohorts, and choice of comparator agents that characterizes the current body of literature

The trial is ongoing, and 64-week data will be available in the future

If your appetite is suppressed, you need to be more intentional, not less

These injectable medications are helping people eat less, lose weight and improve their overall health

Future research should explore the mechanisms underlying these subgroup differences and evaluate the efficacy of combining GLP-1 RAs with SGLT2 inhibitors to leverage their complementary benefits in diverse patient populations